US20020062145A1 - Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method - Google Patents

Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method Download PDF

Info

Publication number
US20020062145A1
US20020062145A1 US09/935,417 US93541701A US2002062145A1 US 20020062145 A1 US20020062145 A1 US 20020062145A1 US 93541701 A US93541701 A US 93541701A US 2002062145 A1 US2002062145 A1 US 2002062145A1
Authority
US
United States
Prior art keywords
balloon
expandable
composite
sleeve
expandable device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/935,417
Inventor
Leon Rudakov
Mir Imran
Linh Dinh
Ara Davidian
Kevin Larkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
CardioVasc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CardioVasc Inc filed Critical CardioVasc Inc
Priority to US09/935,417 priority Critical patent/US20020062145A1/en
Publication of US20020062145A1 publication Critical patent/US20020062145A1/en
Assigned to CARDIOVASC, INC. reassignment CARDIOVASC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHIU, PHILLIP, DANG, MAI HUONG
Assigned to NFOCUS, INC. reassignment NFOCUS, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CARDIOVASC, INC.
Assigned to NFOCUS NEUROMEDICAL, INC. reassignment NFOCUS NEUROMEDICAL, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: NFOCUS, INC.
Priority to US12/105,502 priority patent/US20090043375A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other
    • A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155—Adjacent bands being connected to each other
    • A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body

Definitions

  • This invention relates to a composite expandable device with a polymeric covering on the device and a bioactive coating on device and the polymeric covering, a delivery apparatus and a method.
  • Saphenous vein grafts have heretofore been utilized for bypassing occluded arterial blood vessels in the heart. Because they are vein tissue rather than arterial tissue, they have different characteristics and generally do not function well long term as arterial vessels. Saphenous bypass veins are less muscular and are generally quite flimsy and compliant. When these saphenous vein grafts become diseased with age, stenoses and obstructive deposits which are cheesy or buttery in consistency and which are very malleable are formed which cannot be treated effectively with interventional catheter procedures even when followed with a stent implant.
  • plaque material forming the stenosis tends to ooze through the stent struts and reoccludes flow passage through the stent and the saphenous vein graft.
  • Other vascular obstructions such as in femoral and popliteal vessels and in carotids as well as in native coronary arteries also suffer from occlusions. In many of these cases, plaque proliferates through the stents when stents are deployed in the vessels. Therefore a great need exits for a new and improved device and method to provide a lasting therapeutic relief in such situations.
  • Another object of the invention is to provide a device of the above character which will provide a lasting therapeutic solution to the occurrence of plaque in stents in saphenous vein grafts.
  • Another object of the invention is to provide a device of the above character which can be used for repaving with endothelial cells the portion of the vessel being treated.
  • Another object of the invention is to provide a device of the above character which has physical characteristics which substantially match or mimic the physical characteristics of blood vessels.
  • Another object of the invention is to provide a device of the above character in which a uniformly distributed structural support is provided for the polymeric covering.
  • Another object of the invention is to provide a device of the above character which is very flexible and can bend axially to accommodate the tortuosity of blood vessels.
  • Another object of the invention is to provide a device of the above character which can be placed in tandem with another similar device in a vessel to treat a long stenosis in a vessel.
  • FIG. 1 is a side elevational view of a composite expandable device with a polymeric covering and a bioactive coating thereon, with certain portions broken away, mounted on a balloon delivery catheter.
  • FIG. 2 is a cross-sectional view taken along the line 2 - 2 of FIG. 1.
  • FIG. 3 is a cross-sectional view taken along the line 3 - 3 of FIG. 1.
  • FIG. 4 is an enlarged detail view of the balloon with the composite expandable device mounted thereon shown in FIG. 1.
  • FIG. 5 is a plan view of the expandable device which has been split apart longitudinally and spread out to show its construction.
  • FIG. 6 is a side elevational view of another embodiment of a composite expandable device with polymeric covering and bioactive coating thereon which is tapered and is carried by a tapered balloon for expansion and delivery.
  • FIG. 7 is a schematic illustration of a heart showing the manner in which a saphenous vein graft is treated utilizing the composite expandable device of the present invention.
  • FIG. 8 is an enlarged detail view showing the docking of a tapered composite expandable device being docked with a cylindrical composite expandable device.
  • the composite expandable device incorporating the present invention is for delivery into a vessel carrying blood and comprises an expandable support frame having first and second ends.
  • An impervious polymer sleeve extends over the support frame and may leave the first and second ends of the support frame exposed.
  • a bioactive coating is provided on one or both of the inner and outer surfaces of the polymer sleeve and the frame for enhancing endothelial cell growth on the blood contact surfaces of the polymer sleeve and frame.
  • the composite expandable device 11 as shown is mounted on a delivery apparatus 12 which consists of an expandable balloon 13 mounted on the distal extremity of a shaft or catheter 14 and having a wye fitting 16 mounted on the proximal extremity.
  • the shaft or catheter 14 is provided with a central lumen 17 which is adapted to receive a conventional guide wire 18 through a port 19 provided in the fitting 16 .
  • the catheter shaft 14 is provided with a concentric lumen 21 which is in communication with a port 22 of the fitting 16 .
  • the lumen 21 extends through the balloon 13 and an opening (not shown) is provided in the shaft 14 within the balloon for inflating and deflating the balloon.
  • the composite expandable device 11 consists of an expandable frame 26 which has a polymeric sleeve 27 covering the same.
  • the sleeve has folds 28 therein when the frame is in an unexpanded condition as shown in FIG. 4.
  • the expandable balloon 13 has a substantially continuous diameter and is provided with distal and proximal portions 31 and 32 and an intermediate portion 33 which serves as a working portion of the balloon, having a length which will accept the length of the composite device 11 .
  • the balloon 13 is provided with folds 34 when deflated as shown in FIGS. 1, 3 and 4 .
  • Radiopaque marker bands 36 and 37 are provided on the portion of the shaft 14 extending through the balloon 13 and are mounted in the distal and proximal portions 31 and 32 as shown adjacent to the intermediate portion 33 .
  • marker bands 36 and 37 are within the distal and proximal portions 31 and 32 of the balloon 13 but have a diameter which is substantially greater than the inner diameter of the intermediate portion 33 with the composite expandable device 11 mounted on the intermediate portion 33 to serve as stops or abutments to prevent the composite expandable device 11 from inadvertently slipping off of the balloon 13 during positioning and deployment of the composite expandable device 11 .
  • the frame 26 which forms a part of the composite expandable device 11 consists of a plurality of circumferentially spaced-apart elongated struts 41 having first and second ends 42 and 43 .
  • Foldable links 46 are secured to the first and second ends 42 and 43 and extend circumferentially of the frame 26 and serve in conjunction with the elongate struts to form a circular belt 47 .
  • a plurality of serially-connected belts 47 are provided which are axially aligned with each other.
  • Sinusoidal-shaped end portions 48 and 49 are provided on opposite ends of the plurality of serially-connected belts 47 .
  • Interconnecting means 50 is provided for interconnecting the plurality of belts 47 and the end portions 48 and 49 so that the belts 47 and end portions 48 and 49 extend along an axis while permitting axial bending between the belts 47 and the end portions 48 and 49 while maintaining a constant length of the device 11 .
  • the means 50 consists of at least one strut 51 which is relatively short in length in comparison to the length of the elongate struts 41 and a plurality of S-shaped links 52 .
  • the length of the frame 26 can be readily increased or decreased by changing the number of belts 47 provided in the frame 26 .
  • the frame 26 can be formed of a suitable material such as a metal or plastic. Suitable metals are stainless steel, titanium, and alloys thereof and other biocompatible metals.
  • the plastic can be a polymer. Since the frame to be utilized in the composite expandable device is typically used in a saphenous vein graft, it need not have the radial strength normally required for stents placed in native arterial vessels.
  • the frame 26 has been specifically designed to support the polymer sleeve 27 for use in a saphenous vein graft to closely approximate mechanical properties of the saphenous vein graft. The same principles can be used for a composite device for arterial vessels and other blood vessels. Thus the frame 26 provides the necessary strength and consistency throughout its length while giving good flexibility throughout its length to accommodate movement of the saphenous vein graft.
  • the polymer sleeve extends over substantially the entire length of the frame 26 but leaving end portions 48 and 49 substantially exposed for a purpose hereinafter described.
  • the sleeve 27 typically is formed of a suitable polymer.
  • a suitable polymer One polymer found to be particularly satisfactory is PTFE which is supplied as a tube having a wall thickness ranging from 0.002′′ to 0.010′′ and preferably 0.004′′ to 0.008′′ and having a suitable original diameter as for example 2 to 4.5 mm.
  • the expanded PTFE material should have a pore size of approximately 10 to 50 ⁇ m.
  • the material be expandable from two to six times its original size yet retain elasticity properties to remain tightly over and in close engagement with the frame 26 prior to and after expansion.
  • the sleeve 27 may be secured to the frame 26 so that it does not move axially of the frame 26 during deployment as hereinafter described.
  • the sleeve 27 can be wrapped into a fold or a wing 28 and held in place along a line 61 (see FIG. 4) or tacked by spaced-apart heat seals (not shown) that are easily rupturable upon expansion of the frame 26 . It has been found that such tacking by the use of heat seals on a fold or wing of the polymer sleeve 27 makes it easy for the balloon 13 when expanding to open the sleeve 27 without any significant additional balloon pressure being required.
  • the frame 26 which has been crimped onto the intermediate portion 33 of the balloon 13 and the sleeve 27 wrapped over onto the same and seamed into place will have an overall profile which has a diameter or size which is not greater than or desirably less than the diameters of the proximal and distal portions 31 and 32 . Since the marker bands 36 and 37 have larger diameters than the intermediate portion 33 of the balloon 13 , they will ensure that the composite expandable device consisting of the frame 26 and the sleeve 27 cannot inadvertently slip off of the balloon 13 during the procedure.
  • FIG. 5 Another embodiment of a composite expandable device incorporating the invention is in the device 71 shown in FIG. 5. It is tapered rather than cylindrical to more closely approximate natural vessel geometry.
  • a frame 72 is provided which is constructed in substantially the same manner as frame 26 but with the belts 73 increasing successively in circumference in one direction along the axis of the device 71 by providing foldable links 46 of successively greater lengths to provide the tapered construction shown in which one expandable end portion 76 has a lesser diameter than the other end portion 77 .
  • the means connecting the belts 73 and the end portions 76 and 77 are like the interconnecting means 50 hereinbefore described.
  • a tapered polymer sleeve 81 is provided on the exterior of the frame 72 while leaving the end portions 76 and 77 substantially exposed.
  • a tapered balloon, 86 is disposed within the frame 72 and is utilized for expanding the composite expandable device 71 .
  • the tapered balloon 86 is mounted on the distal extremity of a balloon shaft or catheter 87 and is constructed in the same manner as balloon shaft 14 and provides a delivery apparatus 89 .
  • the surface of the polymer can be characterized as having applied thereto a bioactive coating which is cell friendly and which enhances growth of cells thereon.
  • a low temperature plasma-deposited layer is provided on the surface of the polymer to functionalize the surface and provide free amine groups thereon.
  • a spacer/linker molecular layer is covalently bonded to the plasma-deposited layer.
  • a peptide coating such as P15 is deposited on the spacer/linker layer.
  • the outer surface of the sleeve 27 can be treated first. Thereafter, the sleeve 27 can be inverted by turning it inside out and treating the inside surface which is now outside. Alternatively, both the outside and inside surfaces can be treated at the same time.
  • a tapered composite expandable device 71 it is desirable to first use a tapered composite expandable device 71 , delivering the same by the use of the tapered balloon 86 of the delivery apparatus 89 on a guide wire in a conventional manner through the femoral artery into the aorta, then through the proximal anastomosis 108 and then advanced into a region adjacent the distal anastomosis 109 .
  • the distal tapered balloon 86 is then expanded to expand the device 71 into engagement with the wall of the saphenous vein graft and to thereby enlarge the opening through the saphenous vein graft to enhance blood flow therethrough, through the flow passage formed by the device 71 . Thereafter, the tapered balloon 86 and the delivery apparatus 89 is removed.
  • the tapered device 71 has an inadequate length to treat the entire stenosis and it is desired to place another composite expandable device as for example the device 11 (FIG. 1) in tandem or in series with the device 71 .
  • the shaft 14 of the delivery apparatus 12 can be threaded over the guide wire 18 and a balloon with a composite expandable device 11 mounted thereon advanced into the saphenous vein graft 106 until the distal extremity of the device 11 meets within the proximal larger end 77 of the device 71 .
  • the distal extremity can be docked into the open proximal end of the device 71 .
  • the balloon 13 can be expanded to complete the docking of the distal extremity of the device 11 in the proximal extremity of the device 71 so that they are deployed in the saphenous vein graft 106 in tandem.
  • the balloon 13 then can be deflated and removed with the delivery apparatus 12 along with the guide wire 18 .
  • the positioning of the devices 71 and 11 can be observed fluoroscopically by observing the locations of the radiopaque markers 56 provided on the devices 11 and 71 . If the occlusion in the saphenous vein graft is sufficiently long, an additional device 11 can be placed in tandem with the device 11 already in place.
  • the guide wire can be left in place and another balloon delivery apparatus 12 with a device 11 mounted thereon can be advanced into the saphenous vein graft 106 and the distal extremity docked into the expanded proximal extremity of the already positioned device 11 .
  • the balloon 13 can be deflated and then removed along with the guide wire 18 and the femoral artery closed in an appropriate manner.
  • the balloon expandable devices 11 and 71 form a vascular prosthesis which has mechanical and biomedical properties which re-establish and mimic the composition of the biological function and environment of a healthy natural vessel as for example a recently transplanted saphenous vein graft.
  • the support frame for the polymer sleeve is designed to provide adequate support for the polymer sleeve while still providing appropriate compliance corresponding to that of the vessel in which it is disposed.
  • the device with its free outer ends is capable of firmly engaging the wall of the vessel in which it is disposed to ensure that the device remains in place in the desired position within the vessel after deployment.
  • the delivery apparatus has a low profile which by utilizing a balloon having an intermediate working portion of a lesser diameter retains this low profile even when the composite expandable device is mounted thereon to facilitate positioning and deployment of the device to the site.
  • Use of the polymer sleeve in the device prevents plaque or deposits within the blood vessel as for example a saphenous vein graft from oozing through the interstices of the frame so that there is unimpeded blood flow through the expanded frame.
  • a peptide such as P15

Abstract

A composite expandable device for delivery into a vessel carrying blood comprising an expandable support frame having first and second end portions. An impervious polymer sleeve having inner and outer surfaces extending over the support frame. A coating is disposed on at least one of the inner and outer surfaces of the polymer sleeve for enhancing endothelial cell growth on the device and polymer sleeve.

Description

  • This invention relates to a composite expandable device with a polymeric covering on the device and a bioactive coating on device and the polymeric covering, a delivery apparatus and a method. [0001]
  • Saphenous vein grafts have heretofore been utilized for bypassing occluded arterial blood vessels in the heart. Because they are vein tissue rather than arterial tissue, they have different characteristics and generally do not function well long term as arterial vessels. Saphenous bypass veins are less muscular and are generally quite flimsy and compliant. When these saphenous vein grafts become diseased with age, stenoses and obstructive deposits which are cheesy or buttery in consistency and which are very malleable are formed which cannot be treated effectively with interventional catheter procedures even when followed with a stent implant. The plaque material forming the stenosis tends to ooze through the stent struts and reoccludes flow passage through the stent and the saphenous vein graft. Other vascular obstructions, such as in femoral and popliteal vessels and in carotids as well as in native coronary arteries also suffer from occlusions. In many of these cases, plaque proliferates through the stents when stents are deployed in the vessels. Therefore a great need exits for a new and improved device and method to provide a lasting therapeutic relief in such situations. [0002]
  • In general, it is an object of the present invention to provide a composite expandable device with a substantially impervious polymeric covering thereon with a bioactive coating on the device and covering and a method for using the same which can be utilized for treating occlusions or partial occlusions in blood vessels and particularly saphenous vein grafts. [0003]
  • Another object of the invention is to provide a device of the above character which will provide a lasting therapeutic solution to the occurrence of plaque in stents in saphenous vein grafts. [0004]
  • Another object of the invention is to provide a device of the above character which can be used for repaving with endothelial cells the portion of the vessel being treated. [0005]
  • Another object of the invention is to provide a device of the above character which has physical characteristics which substantially match or mimic the physical characteristics of blood vessels. [0006]
  • Another object of the invention is to provide a device of the above character in which a uniformly distributed structural support is provided for the polymeric covering. [0007]
  • Another object of the invention is to provide a device of the above character which is very flexible and can bend axially to accommodate the tortuosity of blood vessels. [0008]
  • Another object of the invention is to provide a device of the above character which can be placed in tandem with another similar device in a vessel to treat a long stenosis in a vessel.[0009]
  • Additional objects and features of the invention will appear from the following description in which the preferred embodiments are set forth in detail in conjunction with the accompanying drawings. [0010]
  • FIG. 1 is a side elevational view of a composite expandable device with a polymeric covering and a bioactive coating thereon, with certain portions broken away, mounted on a balloon delivery catheter. [0011]
  • FIG. 2 is a cross-sectional view taken along the line [0012] 2-2 of FIG. 1.
  • FIG. 3 is a cross-sectional view taken along the line [0013] 3-3 of FIG. 1.
  • FIG. 4 is an enlarged detail view of the balloon with the composite expandable device mounted thereon shown in FIG. 1. [0014]
  • FIG. 5 is a plan view of the expandable device which has been split apart longitudinally and spread out to show its construction. [0015]
  • FIG. 6 is a side elevational view of another embodiment of a composite expandable device with polymeric covering and bioactive coating thereon which is tapered and is carried by a tapered balloon for expansion and delivery. [0016]
  • FIG. 7 is a schematic illustration of a heart showing the manner in which a saphenous vein graft is treated utilizing the composite expandable device of the present invention. [0017]
  • FIG. 8 is an enlarged detail view showing the docking of a tapered composite expandable device being docked with a cylindrical composite expandable device.[0018]
  • In general, the composite expandable device incorporating the present invention is for delivery into a vessel carrying blood and comprises an expandable support frame having first and second ends. An impervious polymer sleeve extends over the support frame and may leave the first and second ends of the support frame exposed. A bioactive coating is provided on one or both of the inner and outer surfaces of the polymer sleeve and the frame for enhancing endothelial cell growth on the blood contact surfaces of the polymer sleeve and frame. [0019]
  • More in particular, the composite expandable device [0020] 11 as shown is mounted on a delivery apparatus 12 which consists of an expandable balloon 13 mounted on the distal extremity of a shaft or catheter 14 and having a wye fitting 16 mounted on the proximal extremity. The shaft or catheter 14 is provided with a central lumen 17 which is adapted to receive a conventional guide wire 18 through a port 19 provided in the fitting 16. The catheter shaft 14 is provided with a concentric lumen 21 which is in communication with a port 22 of the fitting 16. The lumen 21 extends through the balloon 13 and an opening (not shown) is provided in the shaft 14 within the balloon for inflating and deflating the balloon.
  • The composite expandable device [0021] 11 consists of an expandable frame 26 which has a polymeric sleeve 27 covering the same. The sleeve has folds 28 therein when the frame is in an unexpanded condition as shown in FIG. 4.
  • The [0022] expandable balloon 13 has a substantially continuous diameter and is provided with distal and proximal portions 31 and 32 and an intermediate portion 33 which serves as a working portion of the balloon, having a length which will accept the length of the composite device 11. The balloon 13 is provided with folds 34 when deflated as shown in FIGS. 1, 3 and 4. Radiopaque marker bands 36 and 37 are provided on the portion of the shaft 14 extending through the balloon 13 and are mounted in the distal and proximal portions 31 and 32 as shown adjacent to the intermediate portion 33. These marker bands 36 and 37 are within the distal and proximal portions 31 and 32 of the balloon 13 but have a diameter which is substantially greater than the inner diameter of the intermediate portion 33 with the composite expandable device 11 mounted on the intermediate portion 33 to serve as stops or abutments to prevent the composite expandable device 11 from inadvertently slipping off of the balloon 13 during positioning and deployment of the composite expandable device 11.
  • The [0023] frame 26 which forms a part of the composite expandable device 11 consists of a plurality of circumferentially spaced-apart elongated struts 41 having first and second ends 42 and 43. Foldable links 46 are secured to the first and second ends 42 and 43 and extend circumferentially of the frame 26 and serve in conjunction with the elongate struts to form a circular belt 47. As shown in FIG. 4, a plurality of serially-connected belts 47 are provided which are axially aligned with each other.
  • Sinusoidal-[0024] shaped end portions 48 and 49 are provided on opposite ends of the plurality of serially-connected belts 47. Interconnecting means 50 is provided for interconnecting the plurality of belts 47 and the end portions 48 and 49 so that the belts 47 and end portions 48 and 49 extend along an axis while permitting axial bending between the belts 47 and the end portions 48 and 49 while maintaining a constant length of the device 11. The means 50 consists of at least one strut 51 which is relatively short in length in comparison to the length of the elongate struts 41 and a plurality of S-shaped links 52. Thus, as shown in FIGS. 3 and 4, between each end portion and a belt and between adjacent belts there is provided a single strut 51 and two S-shaped links 52 all of which are spaced 120° apart the interconnecting means between adjacent belts and/or end portions are offset by 60°. Thus, with the construction shown in FIG. 4 there are provided four belts 47 and two end portions 48 and 49 with five sets of interconnecting means 50.
  • It can be seen that the length of the [0025] frame 26 can be readily increased or decreased by changing the number of belts 47 provided in the frame 26.
  • The [0026] frame 26 can be formed of a suitable material such as a metal or plastic. Suitable metals are stainless steel, titanium, and alloys thereof and other biocompatible metals. The plastic can be a polymer. Since the frame to be utilized in the composite expandable device is typically used in a saphenous vein graft, it need not have the radial strength normally required for stents placed in native arterial vessels. The frame 26 has been specifically designed to support the polymer sleeve 27 for use in a saphenous vein graft to closely approximate mechanical properties of the saphenous vein graft. The same principles can be used for a composite device for arterial vessels and other blood vessels. Thus the frame 26 provides the necessary strength and consistency throughout its length while giving good flexibility throughout its length to accommodate movement of the saphenous vein graft.
  • As shown in FIG. 3, the polymer sleeve extends over substantially the entire length of the [0027] frame 26 but leaving end portions 48 and 49 substantially exposed for a purpose hereinafter described. The sleeve 27 typically is formed of a suitable polymer. One polymer found to be particularly satisfactory is PTFE which is supplied as a tube having a wall thickness ranging from 0.002″ to 0.010″ and preferably 0.004″ to 0.008″ and having a suitable original diameter as for example 2 to 4.5 mm. The expanded PTFE material should have a pore size of approximately 10 to 50 μm. In addition in certain applications of this device, it may be desirable that the material be expandable from two to six times its original size yet retain elasticity properties to remain tightly over and in close engagement with the frame 26 prior to and after expansion. After placing the sleeve 27 over the working or intermediate portion 33 of the balloon, the sleeve 27 may be secured to the frame 26 so that it does not move axially of the frame 26 during deployment as hereinafter described. To accomplish this, the sleeve 27 can be wrapped into a fold or a wing 28 and held in place along a line 61 (see FIG. 4) or tacked by spaced-apart heat seals (not shown) that are easily rupturable upon expansion of the frame 26. It has been found that such tacking by the use of heat seals on a fold or wing of the polymer sleeve 27 makes it easy for the balloon 13 when expanding to open the sleeve 27 without any significant additional balloon pressure being required.
  • With such a construction as shown in FIG. 3, the [0028] frame 26 which has been crimped onto the intermediate portion 33 of the balloon 13 and the sleeve 27 wrapped over onto the same and seamed into place will have an overall profile which has a diameter or size which is not greater than or desirably less than the diameters of the proximal and distal portions 31 and 32. Since the marker bands 36 and 37 have larger diameters than the intermediate portion 33 of the balloon 13, they will ensure that the composite expandable device consisting of the frame 26 and the sleeve 27 cannot inadvertently slip off of the balloon 13 during the procedure.
  • Another embodiment of a composite expandable device incorporating the invention is in the [0029] device 71 shown in FIG. 5. It is tapered rather than cylindrical to more closely approximate natural vessel geometry. In this device 71, a frame 72 is provided which is constructed in substantially the same manner as frame 26 but with the belts 73 increasing successively in circumference in one direction along the axis of the device 71 by providing foldable links 46 of successively greater lengths to provide the tapered construction shown in which one expandable end portion 76 has a lesser diameter than the other end portion 77. The means connecting the belts 73 and the end portions 76 and 77 are like the interconnecting means 50 hereinbefore described.
  • A tapered polymer sleeve [0030] 81 is provided on the exterior of the frame 72 while leaving the end portions 76 and 77 substantially exposed. A tapered balloon, 86 is disposed within the frame 72 and is utilized for expanding the composite expandable device 71. The tapered balloon 86 is mounted on the distal extremity of a balloon shaft or catheter 87 and is constructed in the same manner as balloon shaft 14 and provides a delivery apparatus 89.
  • In order to provide a cell-friendly surface or surfaces on the [0031] sleeves 27 and 81, at least one surface of the outer and inner surfaces and preferably both inner and outer surfaces are treated in the manner described in co-pending application Ser. No. ______ filed ______ (A-68316). Thus the surface of the polymer can be characterized as having applied thereto a bioactive coating which is cell friendly and which enhances growth of cells thereon. As described therein, a low temperature plasma-deposited layer is provided on the surface of the polymer to functionalize the surface and provide free amine groups thereon. A spacer/linker molecular layer is covalently bonded to the plasma-deposited layer. A peptide coating such as P15 is deposited on the spacer/linker layer. By way of example, the outer surface of the sleeve 27 can be treated first. Thereafter, the sleeve 27 can be inverted by turning it inside out and treating the inside surface which is now outside. Alternatively, both the outside and inside surfaces can be treated at the same time.
  • Operation and use of the composite [0032] expandable devices 11 and 71 with the delivery apparatus 12 and delivery apparatus 89 may now be briefly described as follows. In this connection let it be assumed that a human heart 101 as shown in FIG. 6 has previously had a coronary artery 102 in which there had been formed therein a substantially total occlusion 103. Also let it be assumed that it was found necessary to perform a bypass operation and to insert a saphenous vein graft utilizing a length of saphenous vein 106 which has one end connected into the aorta 107 of the heart by a proximal anastomosis 108 for a blood supply and bypassing the coronary artery occlusion 103 and making a connection to the coronary artery 102 at a distal anastomosis 109. Now let it be assumed that after a period of time there has been a build-up of plaque forming a stenosis in the saphenous vein graft 106 in the region near the distal anastomosis 109.
  • With such a condition, it is desirable to first use a tapered composite [0033] expandable device 71, delivering the same by the use of the tapered balloon 86 of the delivery apparatus 89 on a guide wire in a conventional manner through the femoral artery into the aorta, then through the proximal anastomosis 108 and then advanced into a region adjacent the distal anastomosis 109. The distal tapered balloon 86 is then expanded to expand the device 71 into engagement with the wall of the saphenous vein graft and to thereby enlarge the opening through the saphenous vein graft to enhance blood flow therethrough, through the flow passage formed by the device 71. Thereafter, the tapered balloon 86 and the delivery apparatus 89 is removed.
  • Let it be assumed that the tapered [0034] device 71 has an inadequate length to treat the entire stenosis and it is desired to place another composite expandable device as for example the device 11 (FIG. 1) in tandem or in series with the device 71. Assuming that the guide wire is in place that was used for deploying the first device 71, the shaft 14 of the delivery apparatus 12 can be threaded over the guide wire 18 and a balloon with a composite expandable device 11 mounted thereon advanced into the saphenous vein graft 106 until the distal extremity of the device 11 meets within the proximal larger end 77 of the device 71. The distal extremity can be docked into the open proximal end of the device 71. Thereafter, the balloon 13 can be expanded to complete the docking of the distal extremity of the device 11 in the proximal extremity of the device 71 so that they are deployed in the saphenous vein graft 106 in tandem. The balloon 13 then can be deflated and removed with the delivery apparatus 12 along with the guide wire 18. The positioning of the devices 71 and 11 can be observed fluoroscopically by observing the locations of the radiopaque markers 56 provided on the devices 11 and 71. If the occlusion in the saphenous vein graft is sufficiently long, an additional device 11 can be placed in tandem with the device 11 already in place. If this is desired, the guide wire can be left in place and another balloon delivery apparatus 12 with a device 11 mounted thereon can be advanced into the saphenous vein graft 106 and the distal extremity docked into the expanded proximal extremity of the already positioned device 11. The balloon 13 can be deflated and then removed along with the guide wire 18 and the femoral artery closed in an appropriate manner.
  • From the foregoing it can be seen that the balloon [0035] expandable devices 11 and 71 form a vascular prosthesis which has mechanical and biomedical properties which re-establish and mimic the composition of the biological function and environment of a healthy natural vessel as for example a recently transplanted saphenous vein graft. The support frame for the polymer sleeve is designed to provide adequate support for the polymer sleeve while still providing appropriate compliance corresponding to that of the vessel in which it is disposed. The device with its free outer ends is capable of firmly engaging the wall of the vessel in which it is disposed to ensure that the device remains in place in the desired position within the vessel after deployment. By the use of cylindrical and tapered devices, it is possible to construct a vascular prosthesis which corresponds to the natural geometry of the vessel. The delivery apparatus has a low profile which by utilizing a balloon having an intermediate working portion of a lesser diameter retains this low profile even when the composite expandable device is mounted thereon to facilitate positioning and deployment of the device to the site. Use of the polymer sleeve in the device prevents plaque or deposits within the blood vessel as for example a saphenous vein graft from oozing through the interstices of the frame so that there is unimpeded blood flow through the expanded frame. By covering the polymer sleeve with a peptide such as P15, endothelial cell growth is stimulated. In this way, it is possible to repave the vessel with endothelial cells, nature's most blood compatible surface, and help prevent further spread or degradation of the lumen in the vessel at that site. The construction of the device permitting axial bending makes it possible for the expanded device to readily flex with the vessel.
  • 1 1 1 15 PRT Artificial Sequence portion of a1 chain of collagen 1 Gly Thr Pro Gly Pro Gln Gly Ile Ala Gly Gln Arg Gly Val Val 1 5 10 15

Claims (16)

What is claimed:
1. A composite expandable device for delivery into a vessel carrying blood comprising an expandable support frame having first and second end portions, an impervious polymer sleeve extending over the support frame and having inner and our surfaces, and a coating disposed on at least one of the inner and outer surfaces of the polymer sleeve for enhancing endothelial cell growth on the polymer sleeve.
2. A device as in claim 1 wherein both the inner and outer surfaces are coated with the coating.
3. A device as in claim 1 wherein the first and second end portions are exposed and free of the sleeve.
4. A device as in claim 1 wherein said expandable support frame and polymer sleeve are cylindrical.
5. A device as in claim 1 wherein said expandable support frame and polymer sleeve are tapered.
6. A device as in claim 1 wherein said expandable support frame is constructed to maintain its length during expansion of the frame.
7. A device as in claim 1 wherein said expandable support frame includes a plurality of axially aligned belts and first and second end portions, each of said belts comprising a plurality of circumferentially spaced struts having first and second ends and foldable links secured to the first and second ends of the struts and interconnecting means serially interconnecting the belts and the first and second end portions to extend along an axis and permitting axial bending between the belts and the end portions while maintaining the length of the device.
8. A device as in claim 7 wherein said interconnecting means includes at least one strut and a plurality of S-shaped links.
9. A device as in claim 7 wherein said interconnecting means includes a single strut and first and second S-shaped links, all spaced 120° apart.
10. A device as in claim 7 wherein said interconnecting means between adjacent belts are offset angularly with respect to each other.
11. A device as in claim 10 wherein said end portions are sinusoidal.
12. A device as in claim 7 further including radiopaque markers carried by the end portions.
13. A device as in claim 1 wherein said sleeve is provided with a fold and further including means for securing said label to said sleeve to inhibit dislodging of the sleeve from the frame during deployment of the device.
14. A delivery apparatus for an expandable device having a length and an inner diameter comprising a shaft, a balloon mounted on the shaft, said shaft having a lumen therein for inflating and deflating the balloon, said balloon being formed with proximal, distal and intermediate portions, said intermediate portion having a length to receive the expandable device, and radiopaque markers carried within the proximal and distal portions of the balloon and sized so that they have a diameter greater than the inner diameter of the expandable device when it is mounted on the intermediate portion of the balloon for securing the expandable device to the intermediate portion to prevent the expandable device from being dislodged during deployment by the delivery apparatus, the proximal and distal portions of the balloon being sized so that they have a size which is greater than the size of the expandable device when placed on the intermediate portion to inhibit inadvertent dislodgment of the expandable device during deployment of the expandable device with the apparatus.
15. A method for deploying a plurality of composite expandable devices comprising an expandable frame having opposite ends at proximal and distal extremities, a polymeric sleeve extending over the frame, with the use of a balloon delivery catheter having an inflatable balloon on the distal extremity thereof comprising the steps of mounting a first composite expandable device on the balloon, utilizing the balloon delivery catheter to deliver the device to the desired site in the vessel, inflating the balloon to expand the device in the vessel, deflating the balloon and removing the balloon from the vessel, utilizing a balloon delivery catheter to deliver a second composite expandable device to the site and docking the distal extremity of the additional composite expandable device in the proximal extremity of the first composite device already in place by causing the extremities to intermesh with each other, expanding the balloon to expand the second composite expandable device to expand the distal extremity within the proximal extremity of the composite expandable device already in place to complete the docking and deflating the balloon and removing the balloon delivery catheter from the vessel.
16. A method as in claim 15 wherein the first device is a tapered device.
US09/935,417 1999-08-30 2001-08-22 Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method Abandoned US20020062145A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/935,417 US20020062145A1 (en) 1999-08-30 2001-08-22 Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method
US12/105,502 US20090043375A1 (en) 1999-08-30 2008-04-18 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/385,691 US6371980B1 (en) 1999-08-30 1999-08-30 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US09/935,417 US20020062145A1 (en) 1999-08-30 2001-08-22 Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/385,691 Continuation US6371980B1 (en) 1999-08-30 1999-08-30 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/105,502 Continuation US20090043375A1 (en) 1999-08-30 2008-04-18 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Publications (1)

Publication Number Publication Date
US20020062145A1 true US20020062145A1 (en) 2002-05-23

Family

ID=23522460

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/385,691 Expired - Lifetime US6371980B1 (en) 1999-08-30 1999-08-30 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US09/935,417 Abandoned US20020062145A1 (en) 1999-08-30 2001-08-22 Composite expandable device with polymeric covering and bioactive coating thereon, delivery apparatus and method
US12/105,502 Abandoned US20090043375A1 (en) 1999-08-30 2008-04-18 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/385,691 Expired - Lifetime US6371980B1 (en) 1999-08-30 1999-08-30 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/105,502 Abandoned US20090043375A1 (en) 1999-08-30 2008-04-18 Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Country Status (1)

Country Link
US (3) US6371980B1 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846872A1 (en) * 2002-11-13 2004-05-14 Hexacath Device forming endoprosthesis with reduced ends comprises distal and proximal ends with reduced transverse section facilitating passage in catheter guide
US20050063937A1 (en) * 2003-09-16 2005-03-24 Cheng Li Multiple-arm peptide compounds, methods of manufacture and use in therapy
WO2005060873A1 (en) * 2003-11-18 2005-07-07 Hexacath Device forming an endoprosthesis having tapered ends
US20060034883A1 (en) * 2001-12-21 2006-02-16 Dang Mai H Composite stent with polymeric covering and bioactive coating
US20060121012A1 (en) * 2000-03-15 2006-06-08 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US20070042017A1 (en) * 2000-03-15 2007-02-22 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US20070128723A1 (en) * 2000-03-15 2007-06-07 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20100198334A1 (en) * 2001-11-23 2010-08-05 Surpass Medical Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US7803183B2 (en) 2000-03-15 2010-09-28 Orbusneich Medical, Inc. Medical device with coating that promotes endothelial cell adherence
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US8974512B2 (en) 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US9320592B2 (en) 2013-03-15 2016-04-26 Covidien Lp Coated medical devices and methods of making and using same
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
US20170232156A1 (en) 2013-11-22 2017-08-17 Covidien Lp Anti-thrombogenic medical devices and methods
US9763977B2 (en) 2003-09-16 2017-09-19 Incube Labs, Llc In vitro bio-reactor circuit
US9789228B2 (en) 2014-12-11 2017-10-17 Covidien Lp Antimicrobial coatings for medical devices and processes for preparing such coatings
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11129621B2 (en) 2018-12-17 2021-09-28 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US11844528B2 (en) 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6371980B1 (en) * 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US7220276B1 (en) * 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US20030114918A1 (en) 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US20030113478A1 (en) * 2001-12-12 2003-06-19 Dang Mai Huong Surface coating method and coated device
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US7316710B1 (en) * 2002-12-30 2008-01-08 Advanced Cardiovascular Systems, Inc. Flexible stent
US7497872B2 (en) * 2004-03-08 2009-03-03 Cook Incorporated Retainer for a stent-graft
EP1734897A4 (en) * 2004-03-31 2010-12-22 Merlin Md Pte Ltd A method for treating aneurysms
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
JP2009506802A (en) * 2005-08-10 2009-02-19 エヌフォーカス ニューロメディカル， インコーポレイテッド Restenosis prevention treatment device
WO2007124201A2 (en) * 2006-02-23 2007-11-01 Saratech, Inc. System s and methods for repairing an annulus
US8845712B2 (en) * 2008-01-15 2014-09-30 W. L. Gore & Associates, Inc. Pleated deployment sheath
US8435282B2 (en) 2009-07-15 2013-05-07 W. L. Gore & Associates, Inc. Tube with reverse necking properties
US8936634B2 (en) * 2009-07-15 2015-01-20 W. L. Gore & Associates, Inc. Self constraining radially expandable medical devices
DE102010009802A1 (en) * 2010-03-01 2011-09-01 Qualimed Innovative Medizinprodukte Gmbh Radially expandable stent
AU2011276503B2 (en) 2010-06-28 2015-09-17 Colibri Heart Value LLC Method and apparatus for the endoluminal delivery of intravascular devices
SG10201601962WA (en) 2010-12-14 2016-04-28 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
ES2943709T3 (en) 2012-04-06 2023-06-15 Merlin Md Pte Ltd Devices to treat an aneurysm
WO2019051476A1 (en) 2017-09-11 2019-03-14 Incubar, LLC Conduit vascular implant sealing device for reducing endoleak
CN109316631B (en) * 2018-09-18 2021-04-20 曾祥军 Preparation method of biological source vein containing venous valve

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5434185A (en) * 1993-05-17 1995-07-18 The University Of Kentucky Research Foundation Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US6371980B1 (en) * 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US6894022B1 (en) * 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635482A (en) * 1989-08-14 1997-06-03 The Regents Of The University Of California Synthetic compounds and compositions with enhanced cell binding
CA2079417C (en) * 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
BE1006440A3 (en) * 1992-12-21 1994-08-30 Dereume Jean Pierre Georges Em Luminal endoprosthesis AND METHOD OF PREPARATION.
US5643580A (en) * 1994-10-17 1997-07-01 Surface Genesis, Inc. Biocompatible coating, medical device using the same and methods
EP0810845A2 (en) * 1995-02-22 1997-12-10 Menlo Care Inc. Covered expanding mesh stent
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US5843117A (en) * 1996-02-14 1998-12-01 Inflow Dynamics Inc. Implantable vascular and endoluminal stents and process of fabricating the same
US5697971A (en) * 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
US6022374A (en) * 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US6019789A (en) * 1998-04-01 2000-02-01 Quanam Medical Corporation Expandable unit cell and intraluminal stent
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6451050B1 (en) * 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5434185A (en) * 1993-05-17 1995-07-18 The University Of Kentucky Research Foundation Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US6894022B1 (en) * 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US6371980B1 (en) * 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method

Cited By (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803183B2 (en) 2000-03-15 2010-09-28 Orbusneich Medical, Inc. Medical device with coating that promotes endothelial cell adherence
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US9364565B2 (en) 2000-03-15 2016-06-14 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US8460367B2 (en) 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20060121012A1 (en) * 2000-03-15 2006-06-08 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US20070042017A1 (en) * 2000-03-15 2007-02-22 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US20070128723A1 (en) * 2000-03-15 2007-06-07 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US7942925B2 (en) 2001-07-09 2011-05-17 Surpass Medical Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US20100198334A1 (en) * 2001-11-23 2010-08-05 Surpass Medical Ltd. Implantable intraluminal device and method of using same in treating aneurysms
US8419787B2 (en) 2001-11-23 2013-04-16 Surpass Medical Ltd Implantable intraluminal device and method of using same in treating aneurysms
US20090062899A1 (en) * 2001-12-21 2009-03-05 Nfocus Neuromedical, Inc. Composite stent with polymeric covering and bioactive coating
US20060034883A1 (en) * 2001-12-21 2006-02-16 Dang Mai H Composite stent with polymeric covering and bioactive coating
FR2846872A1 (en) * 2002-11-13 2004-05-14 Hexacath Device forming endoprosthesis with reduced ends comprises distal and proximal ends with reduced transverse section facilitating passage in catheter guide
US20050063937A1 (en) * 2003-09-16 2005-03-24 Cheng Li Multiple-arm peptide compounds, methods of manufacture and use in therapy
US10016453B2 (en) 2003-09-16 2018-07-10 Incube Labs, Llc In vitro bio-reactor circuit
US9763977B2 (en) 2003-09-16 2017-09-19 Incube Labs, Llc In vitro bio-reactor circuit
WO2005060873A1 (en) * 2003-11-18 2005-07-07 Hexacath Device forming an endoprosthesis having tapered ends
US11844528B2 (en) 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US10064627B2 (en) 2010-09-10 2018-09-04 Covidien Lp Devices and methods for the treatment of vascular defects
US10675037B2 (en) 2010-09-10 2020-06-09 Covidien Lp Devices and methods for the treatment of vascular defects
US11534176B2 (en) 2010-09-10 2022-12-27 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US9844382B2 (en) 2010-09-10 2017-12-19 Covidien Lp Devices and methods for the treatment of vascular defects
US9855052B2 (en) 2010-09-10 2018-01-02 Covidien Lp Devices and methods for the treatment of vascular defects
US10617427B2 (en) 2010-09-10 2020-04-14 Covidien Lp Devices and methods for the treatment of vascular defects
US10617426B2 (en) 2010-09-10 2020-04-14 Covidien Lp Devices and methods for the treatment of vascular defects
US9855051B2 (en) 2010-09-10 2018-01-02 Covidien Lp Devices and methods for the treatment of vascular defects
US8974512B2 (en) 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US10939916B2 (en) 2010-09-10 2021-03-09 Covidien Lp Devices and methods for the treatment of vascular defects
US10898200B2 (en) 2010-09-10 2021-01-26 Covidien Lp Devices and methods for the treatment of vascular defects
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US11786253B2 (en) 2012-11-13 2023-10-17 Covidien Lp Occlusive devices
US11690628B2 (en) 2012-11-13 2023-07-04 Covidien Lp Occlusive devices
US10226366B2 (en) 2013-03-15 2019-03-12 Covidien Lp Anti-thrombogenic medical devices
US11376141B2 (en) 2013-03-15 2022-07-05 Covidien Lp Anti-thrombogenic medical devices
US10695200B2 (en) 2013-03-15 2020-06-30 Covidien Lp Anti-thrombogenic medical devices
US9320592B2 (en) 2013-03-15 2016-04-26 Covidien Lp Coated medical devices and methods of making and using same
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
US20170232156A1 (en) 2013-11-22 2017-08-17 Covidien Lp Anti-thrombogenic medical devices and methods
US11903850B2 (en) 2013-11-22 2024-02-20 Covidien Lp Anti-thrombogenic medical devices and methods
US10835393B2 (en) 2013-11-22 2020-11-17 Covidien Lp Anti-thrombogenic medical devices and methods
US11369497B2 (en) 2013-11-22 2022-06-28 Covidien Lp Anti-thrombogenic medical devices and methods
US10258486B2 (en) 2013-11-22 2019-04-16 Covidien Lp Anti-thrombogenic medical devices and methods
US11406514B2 (en) 2013-11-22 2022-08-09 Covidien Lp Anti-thrombogenic medical devices and methods
US9789228B2 (en) 2014-12-11 2017-10-17 Covidien Lp Antimicrobial coatings for medical devices and processes for preparing such coatings
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US11376012B2 (en) 2016-08-04 2022-07-05 Covidien Lp Devices, systems, and methods for treatment of vascular defects
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11304700B2 (en) 2017-08-22 2022-04-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11678887B2 (en) 2018-12-17 2023-06-20 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11129621B2 (en) 2018-12-17 2021-09-28 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11730485B2 (en) 2018-12-17 2023-08-22 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11324513B2 (en) 2018-12-17 2022-05-10 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11278291B2 (en) 2018-12-17 2022-03-22 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11685007B2 (en) 2019-11-04 2023-06-27 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11679458B2 (en) 2019-11-04 2023-06-20 Covidien Lp Devices, systems, and methods for treating aneurysms
US11717924B2 (en) 2019-11-04 2023-08-08 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects

Also Published As

Publication number Publication date
US6371980B1 (en) 2002-04-16
US20090043375A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
US6371980B1 (en) Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
US5195984A (en) Expandable intraluminal graft
CA1330186C (en) Expandable intraluminal graft
AU741328B2 (en) Microporous stent and implantation device
JP3892907B2 (en) Inflatable and bifurcated support lumen graft
JP3442081B2 (en) Inflatable bifurcated support lumen implant
JP4916616B2 (en) Method for making a self-expanding stent-graft
US5556414A (en) Composite intraluminal graft
AU745092B2 (en) Articulated expandable intraluminal stent
ES2946944T3 (en) Directional expansion of intraluminal devices
US5766201A (en) Expandable catheter
US5667523A (en) Dual supported intraluminal graft
US8882822B2 (en) Non-thrombogenic stent jacket
EP0806191A1 (en) Expandable intraluminal graft or stent
AU736081B2 (en) Expandable supportive bifurcated endoluminal grafts
MXPA96003208A (en) Endoprotesis that has varied amounts of structural resistance on its longi

Legal Events

Date Code Title Description
AS Assignment

Owner name: CARDIOVASC, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DANG, MAI HUONG;CHIU, PHILLIP;REEL/FRAME:013061/0025;SIGNING DATES FROM 20020404 TO 20020405

AS Assignment

Owner name: NFOCUS, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:CARDIOVASC, INC.;REEL/FRAME:020350/0393

Effective date: 20070312

AS Assignment

Owner name: NFOCUS NEUROMEDICAL, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:NFOCUS, INC.;REEL/FRAME:020452/0392

Effective date: 20080117

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION